A Legacy of Quality and Trust in Healthcare

With partners in over 64 markets, all our facilities are compliant to global regulatory standards (EU GMP, US FDA, PICS and WHO approved), and are designed keeping the regulatory guidelines in mind. Investing in technology and expanding our modern manufacturing associations forms the foundation of our quality product and service capabilities.

Asterisk is committed to upholding the regulatory compliance and code standards applicable for its manufacturing, R&D, and development facilities. Our regulatory protocol includes all services from primary assessment and evaluation, to dossier development, submission, and approval acquisition. Our strong dedicated team of 20 pharma regulatory personnel mitigate product registration risks & delays, thereby proactively ensuring the timely registration of products in target markets. This consistent speed and accuracy of our regulatory team ensure the timely launch of products & help meet revenue targets.

While Aterisk has manufacturing units that are equipped to meet international standards, we also possess vertical integration, being involved in every step of the healthcare and drug delivery system. Right from concept formation, R&D, production, quality testing, compliance, and registration to end patient delivery. We have guaranteed a consistent factor of trust with all our partners, while securing EU GMP, US FDA, PICS and WHO approvals. Our supply chain capabilities, allow us to customize each stage of the delivery process even later in the cycle, enabling us to high degree of responsiveness and competitive service.

Both at a corporate and manufacturing unit level, Asterisk has appointed the very best in terms of quality assurance professionals. With a base in Europe, these resources are diligent about ensuring best practices focusing on best-in-class management and quality check systems, that ultimately deliver safe for consumption products. At every stage of manufacturing and development, multiple elements are put through GMP compliance and control checks.

Asterisk has established and quality assured partnerships in over 64 countries. Our sales and marketing functions identify the challenges and opportunities in the market, to create and develop customized strategic plans to foster brand equity in the among partner and patients alike. We do this by identifying the root cause analyses of market roadblocks, while recognizing the opportunity within them to conceptualize solutions that dissolve these challenges, thus creating brand trust.

The foundation of our brand and service lies in catering to the needs and safety of the patient, first. We enable end patients by setting up systems of communication and accountability like side-effect reporting and our pharmacovigilance watch department, advocating always for information dissemination and transparency in the market. Asterisk is empowered with all the qualifications necessary to meet global pharmacovigilance standards. Our Europe and US based pharmaceutical affiliates are equipped, to adhere to EU compliance requirements. All of our partner facilities have passed global regulatory inspections across 64 countries.